Skip to main content

Table 5 Incidence of drug-related adverse events according to liver function

From: Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions

AE

All grades (n = 78)

Grade 3/4 (n = 39)

 
  

Child-Pugh A

Child-Pugh B

P

HFSR

23

10

4

0.340

Diarrhea

19

6

4

0.655

Nausea

7

1

0

0.475

Anorexia

6

4

1

0.510

Fatigue

8

2

1

0.991

Rash/desquamation

15

3

3

0.383

  1. Abbreviations: AE adverse event, HFSR hand-foot skin reaction.